Alibaba's health shift prescribes market medicine

Fri, Mar 06, 2020 - 11:40 AM

Alibaba's new health priorities come at the right time. The e-commerce group is injecting more assets into its healthcare subsidiary, now worth a punchy US$25 billion. It's a timely bet that the coronavirus will accelerate reforms, like opening China's US$370 billion drug industry to Web retailers.

PHOTO: AFP

[HONG KONG] Alibaba's new health priorities come at the right time. The e-commerce group is injecting more assets into its healthcare subsidiary, now worth a punchy US$25 billion. It's a timely bet that the coronavirus will accelerate reforms, like opening China's US$370 billion drug industry to...

To continue reading

for full content

if you are a subscriber

Get our introductory offer at only

$0 .99*/month

Cancel anytime

*$0.99/month for first 3 months

$29.90/month for the next 9 months

Need help?

CALL +65 6388 3838 EMAIL btocs@sph.com.sg

OPERATING HOURS (+8 GMT) MON-FRI: 8:30AM-5:30PM

Register to read this article. Log in if you are already a subscriber. Register to read this article. Log in if you are already a subscriber. Please log in or subscribe to continue reading.